A history of vomiting was also a negative explanatory variable and a negative trend was apparent for decreasing weight-adjusted lumefantrine dose.
← all excerpts
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.
1
—
—